BridgeMD
New treatment option for Hair Loss/Baldness
Official title Autologous Adipose Cells Therapy
ClinicalTrials.gov ID: NCT06869252
What this study is testing
What is Autologous Adipose Cells Therapy?
Autologous Adipose Cells Therapy is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for hair loss/baldness.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 80
You may be able to join if
- Outpatients who express interest in skin rejuvenation, and/or who are experiencing skin conditions, such as winkles, fine lines, loss of skin...
- Outpatients who are experiencing hair loss or hair thinning
- Provision of signed and dated informed consent form
- Clearly stated willingness to comply with all the procedures of the study and availability of the study
- Female and Male aged between 21 to 80 years old 6 Medical clearance by family doctor
You likely can't join if
- Pregnancy or lactation
- Known allergic reaction to components of cell culture media
- Chronic disease , e.g. cardiovascular disease, diabetes, chronic kidney disease, seizures
- Chronic infections, e.g. skin fungi infection, psoriasis
- Chronic wound healing
- Currently taking hormone therapy
See the full eligibility criteria
- Outpatients who express interest in skin rejuvenation, and/or who are experiencing skin conditions, such as winkles, fine lines, loss of skin elasticity, skin pigmentation, scarring.
- Outpatients who are experiencing hair loss or hair thinning
- Provision of signed and dated informed consent form
- Clearly stated willingness to comply with all the procedures of the study and availability of the study
- Female and Male aged between 21 to 80 years old 6 Medical clearance by family doctor
- Pregnancy or lactation
- Known allergic reaction to components of cell culture media
- Chronic disease , e.g. cardiovascular disease, diabetes, chronic kidney disease, seizures
- Chronic infections, e.g. skin fungi infection, psoriasis
- Chronic wound healing
- Currently taking hormone therapy
- History of cancers and active cancers
- Viral infection, e.g. HIV, hepatitis B, influenza, coronaviruses.
The study team makes the final eligibility decision.
Where it's taking place
- Lewes, Delaware, United States
- Newark, Delaware, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lewes, Delaware, United States; Newark, Delaware, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.